Category Archives: COVID-19 Member Posts

The early days of a campus COVID-19 response: pivot and pivot again

By on .

By Lisa V. Adams, MD, and Kavita Kantamneni, MPH When Lisa describes her early days on Dartmouth’s COVID-19 response, she asks people to recall their “first COVID-19 moment,” that instant when they realized this was not a drill, that this was going to be something big and life-altering. For her, that was on Jan. 31, […]

Why has no Gamma variant (P.1) been reported in Africa despite being found in 72 nations in the Americas, Asia, Europe and Australia? 

By on .

By Daniel R. Lucey MD, MPH, FIDSA Every week the World Health Organization posts an epidemiological update that includes global maps (below) and nation-by-nation listing in Annex 1 (below) for each of their four variants of concern: Alpha, Beta, Gamma, and Delta.  Multiple nations in Africa have reported Alpha, Beta, and Delta variants. In contrast, no […]

HHS cites increasing rate of variants P.1 and B.351 in recommending use of Regeneron (but no longer Lilly) monoclonal antibody combination in eight states

By on .

By Daniel R. Lucey MD, MPH, FIDSA On Wednesday (May 26) the Department of Health and Human Services made the clinically-relevant important update below.  (I anticipate more than these eight states to be included in the weeks and months ahead as the variants P.1. and B.1. 351 continue to spread in the United States). ​“Important […]

As substance use disorders rise in the midst of a pandemic, a new law is needed now to facilitate treatment

By on .

While America’s epidemic of opioid use was already a burgeoning health crisis, it has worsened markedly since the onset of the COVID-19 pandemic. Between September 2019 and September 2020, the U.S. Centers for Disease Control and Prevention estimates, deaths caused by opioid overdoses have increased by nearly a third. Dr. Ellen Eaton, of the Outpatient-Based […]

Will the China report on 266 patients Nov. 17-Dec. 31, 2019 be made public by China, WHO, or by WHA resolution next week?

By on .

By Daniel R. Lucey MD, MPH, FIDSA In a recent Science paper by Pekar, Worobey and colleagues titled “Timing the SARS-CoV-2 index case in Hubei province” the authors conclude “Our results define the period between mid-October and mid-November 2019 as the plausible interval when the first case of SARS-CoV-2 emerged in Hubei province.” Referencing reporting […]

Variant B.1.617 spreads in India and UK, and arrives in US: get vaccinated ASAP

By on .

By Daniel R. Lucey MD, MPH, FIDSA The World Health Organization declared the SARS-CoV-2 variant “B.1.617”, first recognized in India, a “variant of concern” May 10. The United Kingdom did the same May 7 for the sublineage “B.1.617.2.” The United States has found and reported only a small number of cases, in at least five […]

Changing the narrative: Caring for Asian American and Pacific Islander patients with HIV

By on .

Wednesday, May 19 is National Asian & Pacific Islander HIV/AIDS Awareness Day. Founded by the Banyan Tree Project, the day serves to raise awareness of the impacts of HIV stigma on Asian and Pacific Islander people. Here, Los Angeles-based physician Dr. Jen Chang discusses the importance of work that provides the support of a community […]

WHO provides update on India’s surging epidemic second wave and variant B.1.617

By on .

By Daniel R. Lucey MD, MPH, FIDSA On April 27 the World Health Organization included in its very helpful weekly epidemiological update on COVID-19 a section on variants, including the one termed “B.1.617” (formerly mis-termed “double mutant”). WHO placed into context the rapidly rising numbers of cases in India with the lower and decreasing numbers […]

Fighting COVID- 19 in Jordan, from early declared victory to extreme burden

By on .

By Mahmoud Shorman, MD, FIDSA, MHA After the reports of the spread of a novel coronavirus in China in the first part of 2020, Jordan was no exception as countries worldwide began putting measures in place to prevent the spread of the virus. By Jan. 26 a protocol designed by Jordan’s Health Ministry with the […]

The COVID Archipelago: Volcanoes and variants

By on .

By Daniel R. Lucey MD, MPH, FIDSA Most archipelagos are created by volcanoes erupting from the ocean floor. Imagining such volcanoes as hotspots of SARS-CoV-2/COVID infections, the virus variants can be imagined as an archipelago of islands above the surface. Each new island has the potential to become its own volcano and spread new variant […]